CTLA4 and head and neck squamous cell carcinoma: Other relevant inhibitory co-signaling molecules expressed in HNSCC that are already the target of therapeutic intervention include CTLA4, LAG3, B7-H3, TIGIT, TIM3, and stimulatory OX40, ICOS, GITR, and 4-1BB (44, 45).